Nathan Herrmann, MD
- 13Articles
- 61.9KReads
- 1999–2020Active
- 52Collaborators
- 600Citations
About
Nathan Herrmann, MD, has authored 13 articles between 1999 and 2020 focusing on neuropsychiatric conditions including Alzheimer disease, depression, dementia, and panic disorder. His research encompasses psychopharmacology, particularly lithium use and its renal effects in older adults, as well as treatment strategies for agitation, apathy, and cognitive impairment in neurodegenerative disorders. Herrmann has also examined prescription patterns and safety profiles of psychiatric medications such as monoamine oxidase inhibitors and benzodiazepines. His work contributes to clinical understanding in neurology, psychiatry, and renal disease.
Publications
Cannabinoids for Agitation and Aggression in AD
January 29, 2019
Lithium Use and Chronic Kidney Disease in Older Adults
August 1, 2017
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
